Nicotine stimulates the expression of cyclooxygenase-2 mRNA via NFκB activation in human gingival fibroblasts

Nicotine, a major component in tobacco smoke, stimulates the synthesis of prostaglandin E-2. We investigated the involvement of the transcription nuclear factor kappa B (NF kappa B) in the nicotine-induced expression of cyclooxygenase-2 (COX-2), a key enzyme for prostaglandin synthesis, in human gingival fibroblasis. Nicotine-stimulated release of prostaglandin E-2 and expression of COX-2 mRNA in a time- and dose-dependent manner. The nicotine-stimulated release of prostaglandin E-2 and expression of COX-2 mRNA and protein were inhibited by an NF kappa B inhibitor, pyrrolidine dithiocarbamate (PDTC), by approximately 50%. Nicotine stimulation of I kappa B alpha, an inhibitor of NF kappa B degradation, was also characterized by Western blotting. Mecamylamine, a specific antagonist of the nicotinic acetylcholine receptor, failed to inhibit the effect of nicotine on prostaglandin E-2 release. When human gingival fibroblasts were incubated with [H-3]-nicotine, uptake of nicotine was observed. These results suggest that nicotine is taken up by human gingival fibroblasts and that it then stimulates COX-2 expression via the activation of NF kappa B and the subsequent release of prostaglandin E-2. (c) 2008 Elsevier Ltd. All rights reserved.